Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (46)
Cancer Statistics, 2005
2005 • 5,487 citations
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
2002 • 4,625 citations
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
1997 • 3,167 citations
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 • 2,879 citations
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
1999 • 2,380 citations
Renal-Cell Carcinoma
1996 • 2,232 citations
Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer
2001 • 1,690 citations
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
1995 • 1,320 citations
An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign Score
2002 • 1,073 citations
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 • 1,029 citations
Pathways of apoptotic and non-apoptotic death in tumour cells
2004 • 1,026 citations
Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity
2005 • 972 citations
Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production
2003 • 933 citations
Classification of renal cell carcinoma
1997 • 887 citations
Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up
2006 • 826 citations
Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
2004 • 801 citations
Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer
2003 • 778 citations
PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
2004 • 748 citations
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
2004 • 742 citations
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma
2003 • 736 citations
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
2001 • 712 citations
A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA
2001 • 706 citations
B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression
2004 • 664 citations
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.
2001 • 625 citations
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells
2004 • 609 citations
Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype
2000 • 534 citations
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.
1998 • 512 citations
Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene Targeting
1998 • 413 citations
Expression of the B7 - related molecule B7 - H1 by glioma cells: a potential mechanism of immune paralysis
2003 • 370 citations
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.
2001 • 329 citations
Inhibition of melanoma tumor growth in vivo by survivin targeting
2001 • 290 citations
Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients.
2001 • 258 citations
Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients.
2001 • 258 citations
Role of survivin and its splice variants in tumorigenesis
2004 • 226 citations
Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference.
2003 • 191 citations
Effects of Survivin Antagonists on Growth of Established Tumors and B7-1 Immunogene Therapy
2001 • 174 citations
Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor
1997 • 162 citations
Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor Aggressiveness
2005 • 155 citations
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer
2003 • 153 citations
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
1999 • 145 citations
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin
2004 • 113 citations
High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma
2006 • 93 citations
Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses
2004 • 75 citations
Mononuclear cell infiltration in clear‐cell renal cell carcinoma independently predicts patient survival
2006 • 73 citations
Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer
2002 • 64 citations
710: High Expression Levels of Survivin Protein are an Independent Predictor of Poor Outcome Among Patients Treated Surgically for Clear Cell Renal Cell Carcinoma
2006 • 4 citations